Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GGet al.(2020) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome J Am Coll Cardiol, 75(2), 133-144 DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641
Rutherford OC, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S(2020) Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvz086, PubMed 31942972
Aamodt IT, Lycholip E, Celutkiene J, von Lueder T, Atar D, Falk RS, Hellesø R, Jaarsma T, Strömberg A, Lie I(2020) Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study J Med Internet Res, 22(1), e15445 DOI 10.2196/15445, PubMed 31909717
